Загрузка...
Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer
BACKGROUND: Ovarian cancer is seventh most common cancer in women worldwide. Approximately 1.3% of women will be diagnosed with ovarian cancer at some point during their life time. The majority of tumours arise from surface of the ovary (epithelial). Two thirds of these women will present with advan...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2016
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6353126/ https://ncbi.nlm.nih.gov/pubmed/27356090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011322.pub2 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|